【结 构 式】 |
【分子编号】47602 【品名】methyl 3-(1-trityl-1H-imidazol-4-yl)propanoate 【CA登记号】 |
【 分 子 式 】C26H24N2O2 【 分 子 量 】396.48884 【元素组成】C 78.76% H 6.1% N 7.07% O 8.07% |
合成路线1
该中间体在本合成路线中的序号:(XI)Synthesis of intermediate (VII): Conversion of 3-fluoroaniline (I) into 2-amino-5-fluorobenzothiazole (III) can be achieved by first coupling with isocyanate (II) followed by hydrolysis with NaOH, reaction with Br2 and finally heating treatment. Dimerization of substituted benzothiazole (III) by means of refluxing aqueous KOH yields disulfide derivative (IV), which is then condensed with substituted benzoyl chloride (V) in refluxing pyridine to afford derivative (VI). Finally, (VI) is converted into intermediate (VII) by treatment with SnCl2 dihydrate in refluxing HCl/EtOH. Alternatively, intermediate (VII) can be synthesized as follows: substituted aniline (VIII) is first brominated via a Sandmeyer reaction with NaNO2 in HBr and CuBr, and then the nitro group is reduced with SnCl2 in refluxing EtOH to provide derivative (IX). Condensation of (IX) with substituted benzoyl chloride (V) in refluxing pyridine yields amide (X), which is then first treated with Lawesson's reagent and HMPA and then with NaH in NMP to afford benzothiazole derivative (XI). Finally, the nitro group of (XI) is reduced with SnCl2 in refluxing EtOH to yield intermediate (VII). Synthesis of EN 295753: The desired compound can finally be obtained by coupling of intermediate (VII) with Boc-Lys(Boc)-OH (XII) by means of carbodiimide WSC.HCl and HOBt in CH2Cl2, followed by Boc removal with HCl (gas) in CH2Cl2.
【1】 Hutchinson, I.; et al.; Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid produgs. J Med Chem 2002, 45, 3, 744. |
【2】 Chua, M.-S.; Westwell, A.D.; Hutchinson, I.P.; Stevens, M.F.G.; Poole, T.D. (Cancer Research Campaign Technology Ltd.); Substd. 2-arylbenzazole cpds. and their use as antitumour agents. WO 0114354 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 20697 | 3-fluoroaniline; 3-fluorophenylamine | 372-19-0 | C6H6FN | 详情 | 详情 |
(II) | 23530 | benzoyl isothiocyanate | 532-55-8 | C8H5NOS | 详情 | 详情 |
(III) | 47594 | 5-fluoro-1,3-benzothiazol-2-amine; 5-fluoro-1,3-benzothiazol-2-ylamine | C7H5FN2S | 详情 | 详情 | |
(IV) | 47595 | 2-[(2-amino-4-fluorophenyl)disulfanyl]-5-fluoroaniline; 2-[(2-amino-4-fluorophenyl)disulfanyl]-5-fluorophenylamine | C12H10F2N2S2 | 详情 | 详情 | |
(V) | 47596 | 3-methyl-4-nitrobenzoyl chloride | 35675-46-8 | C8H6ClNO3 | 详情 | 详情 |
(VI) | 47597 | N-[5-fluoro-2-([4-fluoro-2-[(3-methyl-4-nitrobenzoyl)amino]phenyl]disulfanyl)phenyl]-3-methyl-4-nitrobenzamide | C28H20F2N4O6S2 | 详情 | 详情 | |
(VII) | 47598 | 1-(5-fluoro-1,3-benzothiazol-2-yl)-3-methyl-1lambda(5)-pyridin-4-amine; 1-(5-fluoro-1,3-benzothiazol-2-yl)-3-methyl-1lambda(5)-pyridin-4-ylamine | C13H12FN3S | 详情 | 详情 | |
(VIII) | 22288 | 4-fluoro-2-nitrophenylamine; 4-fluoro-2-nitroaniline | 364-78-3 | C6H5FN2O2 | 详情 | 详情 |
(IX) | 47599 | 2-bromo-5-fluoroaniline; 2-bromo-5-fluorophenylamine | 1003-99-2 | C6H5BrFN | 详情 | 详情 |
(X) | 47600 | N-(2-bromo-5-fluorophenyl)-3-methyl-4-nitrobenzamide | C14H10BrFN2O3 | 详情 | 详情 | |
(XI) | 47602 | methyl 3-(1-trityl-1H-imidazol-4-yl)propanoate | C26H24N2O2 | 详情 | 详情 | |
(XII) | 37991 | (2S)-2,6-bis[(tert-butoxycarbonyl)amino]hexanoic acid | 2483-46-7 | C16H30N2O6 | 详情 | 详情 |
(XIII) | 47601 | tert-butyl (1S)-5-[(tert-butoxycarbonyl)amino]-1-([[1-(5-fluoro-1,3-benzothiazol-2-yl)-3-methyl-1lambda(5)-pyridin-4-yl]amino]carbonyl)pentylcarbamate | C29H40FN5O5S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)Esterification of urocanic acid (I) by means of HCl in MeOH affords methyl ester (II), which is then hydrogenated over Pd/C in MeOH to provide compound (III). Protection of the imidazole ring of (III) with triphenylmethyl chloride (trityl chloride) (IV) and Et3N in acetonitrile yields derivative (V), whose carboxylate moiety is reduced with LiAlH4 in refluxing THF to give alcohol (VI). Trityl removal from compound (VI) with HCl in refluxing EtOH furnishes hydrochloride (VII), which is finally converted into the desired product by condensation in refluxing acetonitrile with isocyanate (VIII) (which in turn can be obtained either by treatment of carboxylic acid (IX) with diphenyl phosphorazidate (DPPA) and Et3N in refluxing dioxane or by reaction of amine (X) with diphosgene (XI) and catalytic charcoal in refluxing ethyl acetate).
【1】 Stark, H.; et al.; [125I]Iodoproxyfan and related compounds: A reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor. J Med Chem 1996, 39, 6, 1220. |
【2】 Sasse, A.; Reidemeister, S.; Stark, H.; et al.; Novel partial agonists for the histamine H3 receptor with high in vitro and in vivo activity. J Med Chem 1999, 42, 20, 4269. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27420 | Urocanic acid; (E)-3-(1H-imidazol-4-yl)-2-propenoic acid | 104-98-3 | C6H6N2O2 | 详情 | 详情 |
(II) | 39976 | methyl (E)-3-(1H-imidazol-4-yl)-2-propenoate | C7H8N2O2 | 详情 | 详情 | |
(III) | 39977 | methyl 3-(1H-imidazol-4-yl)propanoate | C7H10N2O2 | 详情 | 详情 | |
(IV) | 28630 | Triphenylchloromethane; 1-[Chloro(diphenyl)methyl]benzene; Trityl chloride | 76-83-5 | C19H15Cl | 详情 | 详情 |
(V) | 47602 | methyl 3-(1-trityl-1H-imidazol-4-yl)propanoate | C26H24N2O2 | 详情 | 详情 | |
(VI) | 27424 | 3-(1-trityl-1H-imidazol-4-yl)-1-propanol | C25H24N2O | 详情 | 详情 | |
(VII) | 21245 | 3-(1H-imidazol-4-yl)-1-propanol | C6H10N2O | 详情 | 详情 | |
(VIII) | 47603 | (1S)-1,2,2-trimethylpropyl isocyanate; (3S)-3-isocyanato-2,2-dimethylbutane | C7H13NO | 详情 | 详情 | |
(IX) | 47604 | (2S)-2,3,3-trimethylbutyric acid | C7H14O2 | 详情 | 详情 | |
(X) | 47605 | (1S)-1,2,2-trimethylpropylamine; (2S)-3,3-dimethyl-2-butanamine | 22526-47-2 | C6H15N | 详情 | 详情 |
(XI) | 42918 | Chloroformic acid trichloromethyl ester; di-Phosgene; Chloroformic Acid, Trichloromethyl Ester; Trichloromethyl chloroformate; Diphosgene | 503-38-8 | C2Cl4O2 | 详情 | 详情 |